Browsed by
Author: blogadmin

New clues about how ketamine could lead to psychosis.

New clues about how ketamine could lead to psychosis.

Comments 0 Comment

Researchers looked into whether ketamine could cause mental changes like psychosis. They discovered that ketamine increases ambient noise, which may obstruct the brain’s ability to process sensory signals.

As rats were used in the study, more research is required to determine whether the results apply to people. Changes in reality perception, such as persistent delusions, hallucinations, and disorganized thought, are characteristics of schizophrenia. Almost 24 million people around the world are affected by the illness.

There is still no known cause for schizophrenia. Yet, research points to environmental, psychological, and genetic variables as potential causes of the illness.

By blocking NMDA receptors in the brain, the drug ketamine causes a mental state resembling psychosis in healthy humans. As a result, the central nervous system develops an imbalance of excitatory and inhibitory signals, which impacts sensory experience.

According to experts, schizophrenia-related perception abnormalities may be related to similar changes in NMDA receptors. Yet, it hasn’t been made clear how this might be the case.

Ketamine and psychosis

Recently, scientists investigated how ketamine alters sensory perception in rat brains.

They discovered that ketamine increased “background noise” in the brain, which reduced the clarity or intensity of sensory information. They remarked that this might help to explain why persons with schizophrenia or psychosis experience reality differently. The European Journal of Neuroscience published their findings.

These results, according to Dr. Sam Zand, a Las Vegas-based psychiatrist who was not involved in the study, “indicate that malfunction in NMDA receptors may play a role in the development of psychosis.”

“The work offers fresh understandings into the process by which ketamine may cause psychotic symptoms. The results might influence the creation of novel medications for psychosis that target NMDA receptors or brain noise, the researcher continued.

Study design

Seven male lab rats were used in the study to examine how ketamine affected their ability to perceive sensory information. To do this, they first implanted electrodes into rats’ brains to capture electrical activity.

They then recorded the brain’s reactions before and after administering ketamine while simulating their own whiskers. To be more precise, the scientists studied how ketamine affected beta and gamma oscillations in a neuronal network. They carries messages from sensory organs to the brain.

Gamma waves have a frequency range of 30-80 Hz, while beta oscillations have a frequency range of 17-29 Hertz (Hz). Processing sensory data requires the use of frequencies.

In the end, the scientists discovered that even before they stimulated the rats’ whiskers, ketamine enhanced power in both beta and gamma oscillations.

However, they also discovered that the amplitude of the rats’ beta and gamma oscillations dropped post-stimulus and after ketamine administration, which is associated with hampered perception.

They also observed that ketamine enhanced gamma frequency noise, which is related to a reduced capacity for sensory signal processing.

The researchers hypothesised that their findings suggest that increased background noise, which in turn may be brought on by damaged NMDA receptors leading to an imbalance of inhibition and excitation in the brain, may be a trigger for the distorted reality experienced in psychosis and schizophrenia.

According to Dr. Sofya Kulikova, senior research fellow at the HSE University in Perm, Russia, and one of the study’s authors, “The discovered alterations in thalamic and cortical electrical activity associated with ketamine-induced sensory information processing disorders could serve as biomarkers for testing antipsychotic drugs or predicting the course of disease in patients with psychotic spectrum disorders.”

Research limitations

The study was not conducted by Dr. Howard Pratt, a psychiatrist and mental health medical director at Community Health of South Florida. He made it clear that:

The main drawback of these results is that, although a strong association, causation has not yet been shown. There are many potential explanations for conditions like psychosis, including increases in dopamine, which is the focus of treatment for those with a diagnosis of schizophrenia. I’m interested to see what happens as the investigation expands past animal studies.

We also discussed the study’s shortcomings with Dr. James Giordano, the Pellegrino Institute professor of neurology and biochemistry at Georgetown University Medical Center who was not engaged in the study.

The fact that the study solely looked at ketamine-induced effects, he said, “is a key limitation. While valuable and practical for understanding ketamine’s activity in a rat model, it may not provide direct translation to comprehend non-drug-induced dissociative, and psychotic states in humans.”

Dr. Giordano went on to say that it is possible that the effects of ketamine on humans, while undoubtedly dissociative and exhibiting some psychotic traits, are not entirely representative of or identical to the neurological mechanisms underlying other forms of psychosis and schizophreniform disorders.

Possible clinical repercussions

The study’s ramifications, according to Dr. Giordano, are that “[t]hese findings are useful in that evidence of ketamine’s actions at defined brain networks may enable better understanding— and improved clinical applications—of its effects in humans.”

The researcher added, “In addition, by highlighting the functions of these brain nodes and networks involved in mediating dissociative experiences, we may create improved understanding — and possibly treatments for — specific types of drug-induced psychoses, and perhaps other psychotic illnesses, such as forms of schizophrenia, as well.

Larger Trials Needed

Dan Iosifescu, MD, MSc, associate professor of psychiatry at New York University School of Medicine in New York City, commented on the study and said that if the results “were based on a larger study” it would be very important because such patients are currently being denied access to a beneficial treatment due to a theoretical risk of psychosis.

A low risk of psychosis exacerbation following IV ketamine, according to Iosifescu, who is also the director of clinical research at the Kline Institute for Psychiatric Research in Orangeburg, New York, and was not involved in the study, is still possible given that the review is based on a small sample.

Veraart concurred, stating that “well-designed randomised controlled trials should be conducted to ascertain the efficacy, safety, and tolerability of ketamine in depressed individuals with a propensity to psychosis before administration on a large scale is pushed.”

The study received no particular funding. Outside of the submitted work, Veraart has received speaker honoraria from Janssen. Disclosures from the other authors are provided in the original publication. Iosifescu has advised clinics on the most effective ways to administer IV ketamine therapy as a consultant to the Centers of Psychiatric Excellence.

REFERENCES:

For Mental disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?cPath=77_478

Trial Obesity therapy can lead to nausea-less weight loss.

Trial Obesity therapy can lead to nausea-less weight loss.

Comments 0 Comment

Researchers have created a new class of peptides that might offer gastric bypass surgery’s advantages without requiring intrusive procedures. According to recent research, these peptides helped obese rats lose a large amount of weight and lower their blood glucose levels.

The injectable substances minimise eating while also increasing calorie burn, and they do so without the side effects of nausea and vomiting that are frequently associated with modern weight reduction and diabetic medications.

Diabetes and obesity are both major public health issues, with the former being one of the main risk factors for the latter. A good therapeutic option is bariatric surgery, which includes the gastric bypass, gastric sleeve, and gastric band. It can lead to long-term weight loss and even the remission of diabetes.

These procedures, nevertheless, have significant risks, are not appropriate for everyone, and are not easily accessible to the majority of people. Therefore, some researchers propose that a different therapeutic choice would be to treat metabolic problems with medication that mimics the long-term benefits of surgery.

Obesity

According to the National Institutes of Health, obesity and being overweight are chronic illnesses that are widespread in the United States.

These problems can worsen a variety of other medical conditions and are associated with heart disease, diabetes, and cancer.

The following are some of the factors that contribute to obesity:

  • eating habits, such as consuming meals and drinks that are high in calories but poor in nutrients
  • sleep deprivation
  • absence of exercise
  • Many drugs, including those prescribed for diabetes, depression, or high blood pressure
  • genealogy and genetics

Overweight or obesity affects over three-fourths of US adults over the age of 20. Obesity affects 20% of kids between the ages of 2 and 19 years.

Body mass index (BMI) is used by medical practitioners to check for overweight and obesity. The formula is: Height squared divided by weight (in kilos) (in meters.) Online BMI calculators abound, one of which is provided by the CDC.

Sood told that he would like future research on weight loss to evaluate both weight loss and body composition. “We just lack sufficient knowledge to determine whether patients taking gut hormone agonists for weight loss are mostly losing fat or a mixture of fat and muscle,” says the researcher (the latter is more likely). To age properly and retain a strong metabolism as we age, losing muscle would be counterproductive.

Gut peptides

Some patients who have had gastric bypass surgery benefit from specific health advantages linked to adjustments in the gut’s hormone output.

The hormones in question, such as peptide YY (PYY) and glucagon-like peptide-1 (GLP-1), signal fullness, curb hunger, and aid in blood sugar regulation.

Targeting GLP-1 receptors in the pancreas and brain, scientists have created medications that seek to mimic these effects.

These medications have been effective in managing type 2 diabetes and weight loss. There is a need for better solutions with fewer side effects because some people are unable to handle the negative effects of these medications, and studies show that roughly half of those who start taking them stop within a year.

Better option

To meet this demand, a group led by scientists from Syracuse University in New York has created a novel peptide. On March 26–30, they discussed their most current findings at the ACS Spring 2023 meeting.

The researchers suggest that an alternate treatment for those with metabolic issues would be a substance that matches the long-term advantages of gastric bypass surgery.

Several strategies have been devised by researchers to alleviate the negative effects of medications that only target one hormone receptor in the stomach. Designing medications to interact with several receptor types is one approach.

In a prior investigation, the group produced a peptide named GEP44 that activates two peptide YY receptors and one glucagon-like peptide-1 receptor.

When this substance was tested on obese rats, it was discovered that the animals that received it consumed up to 80% less food than usual and on average lost 12% of their body weight over the course of the 16-day experiment.

In a recent study, they compared the novel peptide GEP44’s efficacy in treating obesity to that of the medication liraglutide.

According to the study, rats given GEP44 lost more weight than rats given liraglutide. When tested on rats and shrews, GEP44, unlike liraglutide, did not exhibit any signs of nausea or vomiting.

According to the researchers, this might be as a result of GEP44 activating a number of receptors, which might stop the intracellular signalling cascade that results in these symptoms.

Weight loss and high energy expenditure

This study also suggests that the weight reduction brought on by GEP44 is a result of increased energy expenditure rather than just a decrease in food consumption. The manifestation of this rise in energy expenditure can take several forms, including an increase in heart rate, body temperature, or physical activity.

By directing glucose into muscle tissue to be used as fuel and by transforming specific pancreatic cells into cells that produce insulin, peptide treatments like GEP44 not only aid in weight reduction but also aid in lowering blood sugar levels.

GEP44 must be administered numerous times daily to maintain its effectiveness because it has a brief half-life in the body. The team has created a novel peptide, however, that requires only one or two injections per week and has a far longer lifespan.

The researchers discovered that rats treated with this novel molecule continue to lose weight even after the treatment has ceased, which is unusual for medications currently on the market that have been licenced to treat obesity.

“Obesity is obviously an increasing epidemic worldwide,” Dr. Becca Krukowski, professor of public health sciences at the University of Virginia and a non-participant in this study, told us.

What does it implies?

Although these are preliminary results in lab animals, Dr. Krukowski said that “over time, our research may lead to novel drugs that are safe and beneficial for patients.” But before being widely administered, this medication would need to go through the deliberate deliberate slow and thorough multi-stage and multi-year testing process, she warned.

However, if this treatment characteristic was verified in trials with humans, Krukowski continued, “the possible lack of weight regain after ceasing treatment would be extremely interesting.”

Both positive and negative impacts from this research, according to Bishoff, are possible. “The benefits being that patients can take lesser doses of medications that can deliver desired results while reducing nausea and vomiting side effects.

On the other hand, it’s possible that weight loss medications lower caloric intake to the point of malnutrition or deficiency. In the end, additional study will be required, which may take several years.

Although there may be some medical advantages to weight reduction medications, it’s crucial that patients understand they shouldn’t be used as a substitute for a healthy lifestyle. They can be viewed as a tool as opposed to a fix. When controlling weight and diabetes, eating a variety of well-balanced meals, sticking to daily caloric goals, and exercising frequently should always be encouraged, according to Haley Bishoff.

REFERENCES:

For Weight loss medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?therapy=20

Can vegan protein support muscle as good as animal protein?

Can vegan protein support muscle as good as animal protein?

Comments 0 Comment

A recent study looked at whether a vegan diet containing protein from non-animal sources might support muscle growth and repair during strength training just as well as a diet containing animal protein.

Young, healthy adults who were divided into two groups and given high-protein diets based on either animals or plants were used in the study.

Findings revealed that muscle mass and strength gains were comparable across the two groups, proving that resistance exercise combined with a high-protein, non-animal derived diet can be just as effective as a diet heavy in animal derived protein sources.

A recent study demonstrated that mycoprotein generated from fungi is just as effective as animal protein at promoting muscle growth during resistance exercise.

Two sections made up the study. 16 young, healthy persons were divided into two groups for the first stage of the study—eight men and eight women.

Both groups engaged in daily leg workouts, but only one (designated OMNI1) consumed a diet high in animal protein, while the other (designated VEG1) consumed a diet high in non-animal sources of protein.

The amount of muscle protein produced both during exercise and during rest was quantified by the researchers.

In the second portion of the trial, 22 young, healthy adults (11 men and 11 women) engaged in a 10-week leg training regimen five days per week. Both high-protein diets made of non-animal sources and high-protein diets made of animal sources were consumed by some of them (OMNI2) (VEG2).

Before and after the program, as well as two and five weeks into it, the research team examined the size of the leg muscles as well as the size of the body’s overall muscles, strength, and function.

Researchers discovered that compared to when the legs were at rest, exercising the legs boosted the rate of muscle protein creation by roughly 12%.

The amino acid content can differ

Amino acids make up proteins. Over 20 distinct amino acids are used by the human body to create proteins. While your body can produce some amino acids on its own, nine of them are considered to be essential and must be obtained through diet.

The kinds of amino acids present in different protein sources might differ significantly. Animal proteins are typically referred to as complete proteins since they include all nine necessary amino acids.

Many additional plant foods are regarded as incomplete sources of protein, despite the fact that some plant proteins, such as pea protein and soybeans, are also full protein sources.

This means that while plant-based foods like wheat, beans, and peanuts are high in total protein, they also lack one or more important amino acids. To meet your body’s requirements, you can still readily combine these partial plant protein sources.

A nice example of a combination that yields a complete protein source is a peanut butter sandwich. Peanuts are high in the amino acid lysine, whereas the wheat used to produce bread is deficient in it, making them a complete protein meal or snack.

To make sure they get all the necessary amino acids, persons following a vegetarian or vegan diet should consume a range of plant proteins.

Rich protein sources

You can choose from a huge selection of sources of plant and animal protein.

Animal protein sources

Among the many sources of animal proteins are:

  • eggs
  • seafood and fish
  • fatty meat
  • poultry
  • Wild animal
  • dairy items like cheese, yoghurt, and milk

Typically, sources of animal protein also contain additional crucial elements, such as heme iron and vitamin B12. Compared to non-heme iron, which is present in plant foods, heme iron is more easily absorbed.

It’s important to remember that some animal proteins are less nutrient-dense than others. For instance, highly processed animal foods like hot dogs and chicken nuggets are bad for your health since they are high in unhealthy fats and sodium.

Choose nutrient-dense sources of animal protein instead, such as whole eggs, salmon, chicken, turkey, and shellfish.

Plant protein sources

Plant proteins can be found in a variety of places, including:

  • beans
  • nuts
  • legumes
  • goods made from soybeans include tofu, tempeh, and edamame
  • buckwheat
  • Isaiah bread
  • quinoa
  • wheat
  • a wild rice
  • dietary yeast
  • the chia seed
  • seed hemp
  • spirulina

All nine essential amino acids are present in Ezekiel bread, quinoa, buckwheat, spirulina, soybeans, nutritional yeast, chia seeds, and hemp seeds, making them complete protein sources. Some plant protein sources, such as beans, nuts, legumes, wheat, and wild rice, are deficient in one or more essential amino acids.

Getting all the required amino acids on an entirely plant-based diet is still doable, it may just require a bit more work because plant foods contain various levels of different amino acids.

You may make sure that you’re getting all the necessary amino acids in your diet by consuming a varied diet and combining complimentary plant proteins, such in the aforementioned peanut butter sandwich.

Other complete protein combos include pasta salad with kidney beans, rice and beans, and hummus and pita bread.

Plant protein health benefits

Compared to diets high in animal protein, plant-based diets have been linked to considerable drops in blood pressure. Also, research indicates that vegetarians have a lower body mass index, lower cholesterol levels, and a decreased risk of stroke, cancer, and heart disease death than meat eaters.

Yet not all plant-based diets are equal, and not all plant-based foods are automatically good for your heart. One study linked a lower risk of heart disease to plant-based diets high in nutrient-dense plant foods such as whole grains, vegetables, nuts, and seeds.

Conversely, plant-based diets strong in processed grains and less nutrient-dense foods like fried veggies were linked to a higher risk.

Blood sugar control may also be enhanced by plant-based diets. Several observational studies have demonstrated the value of these diets in the management and prevention of type 2 diabetes.

The incidence of type 2 diabetes is greatly reduced with diets high in nutrient-dense plant foods, such as whole grains, fruits, vegetables, nuts, legumes, and vegetable oils.

Although these findings are encouraging, they do not prove that these health advantages derive from cutting out sources of animal protein; rather, the advantages may come from consuming more nutrient-dense plant foods.

Animal protein health benefits

Also linked to beneficial health consequences are specific animal protein sources. For instance, regular fish consumption has been associated with a variety of health advantages, such as a decreased risk of cognitive decline and heart disease.

Moreover, consuming animal protein has been associated with a rise in lean muscle mass and a reduction in the aging-related loss of muscle.

Some animal protein sources have been associated to lowered cholesterol levels, increased muscle mass, and lowered risk of heart disease.

Animal protein not essential for muscle building

According to James Dixon, a certified personal trainer and expert in fitness and nutrition, “the findings of this study are significant since they cast doubt on the widely held notion that animal protein is required for muscle growth.”

The results are encouraging and support the idea that more individuals should promote a vegan diet and give up eating meat. In my opinion, this study also emphasises the significance of both animal and plant-based protein sources when formulating diets for people who practise resistance exercise, said Dixon.

He said that people who might have negative reactions to products like Quorn might look for other protein sources. “I notice a movement in focus on tailored diets rather than the conventional idea that vegan diets are tougher for people growing muscles and resistance training,” he said.

This study will increase interest in plant-based proteins, and we might soon see widespread trends toward vegetarian and vegan diets. Growing interest will be shown in alternative protein sources outside mycoprotein that might be just as efficient. James Dixon stated that people can include protein sources such as beans, nuts, seeds, whole grains, vegetables, soy products, or other wheat-based proteins.

Plant-based protein sources of the future

Dixon noted that, despite the fact that Quorn was utilised in the study, “some forms of mushrooms or microalgae are being explored as potential plant-based protein sources.”

He claimed that “mushroom protein based on mycelium is high in protein and can be generated from agricultural waste.”

As plant-based protein sources, spirulina and chlorella are being researched. The process is more environmentally friendly and sustainable because these protein-rich microalgae need minimal space and water to thrive, Dixon noted.

In the end, more protein sources, including goods derived from microalgae, will be created, expanding the possibilities available to the general people. People will find it easier to include more plant-based protein sources in their diets as a result of this.

REFERENCES:

For Muscle disease medications that have been suggested by doctors worldwide are available here https://mygenericpharmacy.com/index.php?cPath=28

Amino acid: A key in improving depression treatment.

Amino acid: A key in improving depression treatment.

Comments 0 Comment

The role of a receptor called GPR158 in depression was discovered by researchers at the University of Florida over the course of a 15-year investigation.

In a study, mice who had their GPR158 expression suppressed were less likely to experience stress-related sadness. The structure of GPR158 was discovered by the researchers, and this allowed them to connect it to the amino acid glycine.

Many drugs exist to treat depression, which affects millions of people, but it can be challenging to select the proper one.

Scientists at the Herbert Wertheim UF Scripps Center for Biomedical Innovation and Technology uncovered a finding that revealed how an amino acid is related to depression while studying neurotransmitters.

The revelation was the result of more than ten years of investigation into the functioning of brain cell signalling. Although though discovering a connection to depression was not the original aim of the study, the researchers are enthusiastic about their findings since they potentially influence how depression will be treated in the future.

Depression

In the United States, depression affects over 21 million adults each year, according to the National Institute of Mental Health (NIMH). The COVID-19 pandemic saw a sharp increase in depression rates, which have since persisted and are now a serious issue. Rates among children under 18 are also rising.

While some people suffer situational depression as a result of external factors (such losing a loved one), other people struggle with depression for extended periods of time and it can progress into Major Depressive Disorder.

The NIMH includes the following indications and symptoms of depression among others:

  • recurring sense of sadness
  • feeling a sense of emptiness
  • experiencing a decline in energy or weariness
  • having difficulties sleeping
  • feeling suicidal thoughts

Individuals who have persistent depressive symptoms may require medical attention. To treat the symptoms of depression, doctors may give drugs, offer treatment, or advise lifestyle modifications.

Tricyclic antidepressants (like imipramine or amitriptyline), selective serotonin reuptake inhibitors (like sertraline or escitalopram), and serotonin-norepinephrine reuptake inhibitors are a few examples of depression drugs (such as duloxetine or venlafaxine).

Those on antidepressants should consult with their healthcare providers frequently and inform them of any suicidal thoughts because these medications can have negative effects, including thoughts of suicide.

Brain cell receptors and depression

The goal of the writers was not to find a connection to depression at first. 15 years ago, they set out to study how brain cell receptors function, and they have achieved that goal.

Prof. Kirill Martemyanov, one of the study’s authors, stated: “Fifteen years ago we discovered a binding partner for proteins we were interested in, which led us to this new receptor.” “We’ve been unravelling this for a while now.”

Professor Martemyanov teaches at the University of Florida Health’s Department of Neurology.

The next several years saw the discovery of the GPR158 receptor by the researchers. In experiments with mice, they discovered that a mouse would be more resistant to stress-induced depression if that receptor was suppressed in the body.

Amino acid treating depression

A 2017 assessment of the literature concluded that glycine is “one of the most significant and straightforward non-essential amino acids in humans, animals, and many mammals.”

The scientists were shocked to learn that GPR158 was an inhibitor when they realised that glycine was the signal’s sender and that it binds to glycine; they changed its name to mGlyR as a result (metabotropic glycine receptor).

The identification of mGlyR should pave the way for fresh investigation into the management of depression, which Prof. Martemyanov intends to do.

Expert responses

Medical News Today spoke with Dr. Simon Faynboym, a physician who has experience working with the American Psychiatric Association.

Dr. Faynboym stated that the findings “essentially shows that glycine can interact with the GPR158 system.” The researchers demonstrate a biochemical mechanism, but the most significant lesson is that this process may represent the link between glycine and taurine’s potential antidepressant qualities.

Currently serving as a delegate to the California Medical Association is Dr. Faynboym. Dr. Faynboym acknowledged the significance of the study but also emphasized that depression is “very complex” and that other neurotransmitters are involved.

Dr. Faynboym remarked that there are numerous factors at play while dealing with depression. “Depression involves several neuronal networks, various neurotransmitters leaving and entering neurons at various rates, and impacts all areas of the brain. Because of the dynamics of the brain, one of the most complicated medical specialisations is mental health.

Dr. Faynboym emphasised the significance of this kind of research in light of this. Since they provide another glimpse behind the curtain of the big unknown that is the brain, research pieces like this one advance the science of psychiatry.

A psychiatrist from Palm Beach Gardens, Florida named Dr. Jessica Turner also discussed the study’s findings.

The medial prefrontal cortex is a well-known brain region associated with depression, and this work suggests targeting a specific receptor there, according to Dr. Turner. “We anticipate providing better, more efficient alleviation for people who are depressed in the future with more focused treatments.”

REFERENCES:

For more details, kindly visit below.

Common Dry-Cleaning Agent May lead to Parkinson’s Disease

Common Dry-Cleaning Agent May lead to Parkinson’s Disease

Comments 0 Comment

Trichloroethylene (TCE), a chemical, has been linked by some researchers to Parkinson’s disease. Dry cleaning, degreasing, and even decaffeinating coffee have all been common uses for TCE.

According to recent study, the chemical’s capacity to reach the brain and harm cell mitochondria may be the root of the problem.

The authors claim that the chemical’s influence might be “enormous” given how commonplace it is in the environment. TCE should be outlawed, and people should be shielded from more exposure, as suggested alternatives.

According to the Parkinson’s Foundation, the substania nigra, a region of the brain that includes cells that create the neurotransmitter dopamine, is affected by Parkinson’s disease, a neurodegenerative condition.

Parkinson’s disease patients endure tremors, slowness of movement, limb stiffness, and balance issues.

Muhammed Ali and Michael J. Fox are two well-known public celebrities who suffer with the illness.

According to the authors, up to a third of the groundwater in the United States has TCE pollution. The chemical is additionally present in Camp Lejeune, a Marine Corps base, and 15 Superfund sites in Silicon Valley.

What is trichloroethylene (TCE)?

TCE is a chemical that is a colourless liquid that does not exist in nature. It is well known to smell like chloroform.

This substance can be found in a wide range of goods and businesses, such as:

  • industry-wide dry cleaning
  • metal scrubbing
  • wiping cloths
  • carpet and garment stain removers
  • lubricants
  • aerosol adhesives

Using TCE-containing products or working in a TCE-containing plant are two ways that people can be exposed to the chemical.

TCE can also contaminate our air, water, and food and drink by leaking into the soil, water, and air near where it is used or disposed of. High levels of TCE exposure can cause the following symptoms:

  • dizziness
  • headaches
  • confusion
  • nausea
  • facial paralysis

Link between TCE and Parkinson’s disease

According to the study, which was published in the Journal of Parkinson’s Disease, there may be a “invisible” cause of Parkinson’s disease that is related to the widespread use of TCE.

Dr. James Beck, Chief Scientific Officer of the Parkinson’s Foundation, commented on the study, saying, “We have known for some years that TCE exposure and Parkinson’s disease are related. I believe that this opinion piece effectively highlights the risks associated with TCE exposure.

The researchers’ findings are discussed in the study together with the evidence tying TCE to Parkinson’s disease.

TCE is lipophilic, as the scientists explain in their research, which means that it has a propensity to dissolve in fatty tissues. This makes it simple for it to enter the brain and other bodily tissues where it can wreck havoc with cell mitochondrial function. This sort of toxin is extremely toxic to dopamine-producing cells, which may help to explain how exposure to TCE might cause Parkinson’s disease.

Seven other people, including the late Senator Johnny Isakson, are also profiled. Isakson employed TCE to degrease aircraft during his time in the military; as a result, he eventually developed Parkinson’s disease as well as renal cell carcinoma, a cancer associated to TCE exposure.

The matter was initially brought to his notice, according to co-author Dr. Ray Dorsey, when his colleague, Dr. Caroline Tanner, told him about the exposures at Camp Lejeune.

TCE poses a “enormous” risk to the general public’s health, he claimed. “At one time, it was used by 10 million Americans, including printers, embalmers, mechanics, dry cleaners, chip manufacturers, engineers, painters, metal workers, pilots and others. It has been absorbed into the environment by millions more people.

Avoiding exposure to TCE

The issue of TCE contamination, according to Dorsey, requires a few actions. It must be prohibited first, along with tetrachloroethylene (PCE), another industrial solvent.

Second, home remediation systems such to those used for radon must be deployed to alert and protect persons who are at danger of exposure.

The connection between TCE and Parkinson’s disease, he added, has to be explored further through research. People can be exposed to TCE through contaminated soil, food, water, air, or direct skin contact, according to the U.S. Centers for Disease Control and Prevention.

You are most likely to become exposed by drinking polluted water, but you can also become exposed through the air as it is released from contaminated water, as a third of all groundwater may be affected.

Working in a sector where TCE is manufactured or utilised, like the degreasing business, is a significant additional method that you could be exposed to it. It can enter the body by coming into direct touch with the skin or by inhaling the vapours.

You may also be exposed through contaminated soil, such as that found in landfills. Moreover, TCE can enter your body through the consumption of contaminated foods or contact with consumer products that contain it.

According to the CDC, TCE is a common solvent used in a variety of products, including cold metal cleaners, adhesives, lubricants, paints, varnishes, paint strippers, and paints. Labels for these goods should include instructions on how to reduce exposure.

The Occupational Safety and Health Administration (OSHA) also mandates that your company give you a material safety data sheet (MSDS) outlining the dangers and proper handling techniques for any chemicals you use at work.

When exposed to TCE

A doctor can check for TCE in your blood, breath, or urine if you’ve recently been exposed to the substance, according to the Agency for Toxic Substances and Disease Registry (ATSDR).

It can also be tested for in the environment you have visited. But, once you’ve been exposed, there is no cure to get it out of your system. Either your breath will expel it or your kidneys will excrete it into your urine.

They advise avoiding any known toxic regions, such as those with tainted water, soil, or air.

You should always use items containing TCE in well-ventilated areas with the appropriate personal protective equipment, such as chemical-protection gloves, safety goggles, and respirators, in addition to adhering to any safety advice on such products.

High TCE exposure can, in the short term, irritate people and even make them pass out or become fatally ill. If you have been exposed to the chemical extensively, it is crucial to seek immediate medical care.

The individual should also be transferred to clean air, and any contaminated clothing should be taken off, if it’s safe to do so. If the skin or eyes have been exposed, thoroughly rinse them with water.

Kidney cancer and Parkinson’s disease have both been associated with long-term TCE exposure. The ATSDR advises that the greatest form of protection is to shield yourself from exposure altogether.

REFERENCES:

For more details, kindly visit below.

Explore the latest link between MS and Your Gut.

Explore the latest link between MS and Your Gut.

Comments 0 Comment

The central nervous system is impacted by the chronic disease known as multiple sclerosis (MS). When the immune system targets the outer layer of nerve cells, symptoms including weakness in the muscles and visual issues appear.

MS’s precise causation is unknown, however scientists believe that a number of variables may be involved. A recent study discovered that MS may be brought on in persons with a genetic predisposition by a toxin produced by a common gut bacterium.

Multiple sclerosis (MS) is a persistent nerve system disease. Young adults between the ages of 20 and 40 are the most frequently affected, and women are more likely than males to experience it.

There are around 2.8 million MS sufferers worldwide, and the number is growing, according to the Multiple Sclerosis International Federation (MSIF).

Symptoms of Multiple Sclerosis

The immune system of the affected person destroys the myelin sheath that protects the nerve fibers in this autoimmune illness. Sclerosis is a scar or lesion that results from damage. These lesions, which most frequently affect the central nervous system, can cause a variety of symptoms, such as:

Relapsing-remitting MS, the most prevalent type of MS that accounts for 85% of cases, is characterised by episodes of new or worsening symptoms and intervals during which symptoms subside or go away.

Scientists believe that environmental variables and genetic vulnerability may play a role in the development of the illness, while the specific reason is yet unknown. MS is riddled with many mysteries.

Epsilon toxin, which is produced by a bacteria that may be found in the small intestine, has now been linked to the development of MS and the maintenance of symptoms, according to study conducted by researchers at Weill Cornell Medicine’s Brain and Mind Research Center.

How the gut microbiota affects MS?

The trillions of bacteria that reside in your digestive system make up the gut microbiota. The majority of microbes are bacteria, but they can also include viruses, fungi, and the microscopic, single-celled creatures known as protozoa.

In general, these bacteria are beneficial and even essential to our health. Yet, dysbiosis, or an out-of-balance microbiota, can cause issues. According to studies, alterations in the microbiota may be a factor in various autoimmune diseases.

In MS patients, changes to the gut flora are frequent. According to this recent study, patients with MS are more likely than healthy controls to carry the pathogen Clostridium perfringens. Epsilon toxin, which is produced by C. perfringens, opens the blood arteries in the brain and permits inflammatory cells to enter the central nervous system (CNS).

What is the epsilon toxin?

Dr. Barbara Giesser stated that the researchers “investigated how the toxin induced an MS-like condition in a mouse model using unique and sensitive techniques to determine the presence of the bacterium.

The scientists collected faeces from both MS patients and healthy controls. They used polymerase chain reaction (PCR) analysis to examine these samples in order to find the epsilon toxin (ETX) gene, which is only present in C. perfringens.

They discovered that the ETX gene was present in 61% of samples from MS patients but only in 13% of those from healthy controls. Also, they discovered that compared to age- and sex-matched healthy controls, MS patients had a higher likelihood of having ETX-positive C. perfringens invade their gut microbiome.

Treatments to target this toxin

The current amount of knowledge regarding the gut microbiome in MS patients is expanded upon by this study. It has been demonstrated to respond to treatment with various disease-modifying treatments and is known to differ from those of non-MS controls, according to Dr. Barbara Giesser.

Epsilon toxin is only produced by C. perfringens during the rapid development phase. The researchers hypothesise that ETX is the cause of MS lesions, which would explain why the illness is episodic and manifests less symptoms when the toxin-producing bacteria are absent.

They draw the conclusion that the bacterium, its toxin, and MS exhibit a robust clinical connection. According to Dr. Giesser, this finding raises the prospect of therapies that target this pathway:

“The toxin facilitates central nervous system access for immune cells. This implies that medications that target the bacterium or the toxin may be effective in treating the condition.

The researchers point out that clinical trials would be required to see whether this could result in MS treatments.

Healthy microbiome

The development of MS may be significantly influenced by the gut microbiome, according to studies. An analysis of multiple research published in 2017 discovered that nutrition might be used to alter the gut flora and alter the course of MS.

The advantages of keeping a healthy gut microbiota are becoming more widely understood, and this study provides more proof that an unbalanced microbiota may lead to the onset of disease.

A healthy diet and lifestyle that promote the growth of advantageous gut flora may potentially lower the risk of MS as well as the risk of many other illnesses.

Improve gut health

Some elements, such as genetics and environment, are beyond your control. Although our gut microbiota is set up early in life, there are some things that can change it.

Certain modifications enhance the diversity and health of our microbiome. Alterations may be harmful.

These are some actions you may do to encourage a balanced, healthy gut microbiome:

  • Consume more fibre. All of the little microorganisms in your gut can eat fibre. Fruits, vegetables, beans, lentils, nuts, seeds, and whole grains all contain fibre.
  • Drink less alcohol. There is evidence that alcohol causes dysbiosis. You might want to think about reducing your drinking if you do.
  • Consume fermented food. Foods that have been fermented are sources of good bacteria and may be beneficial to health. Among the foods that are fermented include kimchi, tempeh, yoghurt, kefir, miso, and sauerkraut.
  • Stress management. Your gut microbiota’s state of health can be impacted by stress. To manage tension, try some stress-relieving exercises like yoga or meditation.
  • Don’t overuse antibiotics. Antibiotics can kill some of the helpful bacteria in addition to the harmful ones. Dysbiosis may result from this. Antibiotics should only be used as necessary, and they should be taken exactly as prescribed. Some of the beneficial bacteria may be restored by taking a probiotic supplement.
  • Look into probiotic dietary supplements. Supplements with probiotics may be beneficial. To determine the appropriate dosage and strain for particular ailments, more research is required. Start with the US Probiotic Guide if you want to.

Conclusive note

  • The human body is home to trillions of microorganisms. The gut contains the majority of them.
  • The possibility that the sorts of bacteria in our guts may have an impact on our health is intriguing.
  • Dysbiosis is more likely to occur in MS patients. When the gut microbiota is out of equilibrium, it is called dysbiosis. Inflammation and autoimmune illnesses are now more likely as a result.
  • A healthy gut microbiota can be supported by consuming fermented foods and a high-fiber diet.
  • There is continuing research into the potential benefits of altering the gut microbiome for MS patients.

REFERENCES:

For more details, kindly visit below.

Secrets your heart rate tells about your health.

Secrets your heart rate tells about your health.

Comments 0 Comment

Your heart attack risk and aerobic capacity can be determined by your pulse, both at rest and during exercise.

Your grandma might have called your heart “your ticker,” but that moniker has turned out to be inaccurate. A healthy heart doesn’t beat like a clock every time. As your activities change throughout the day, it speeds up and slows down to match your fluctuating requirement for oxygen. Everybody’s idea of what constitutes a “normal” heart rate is different. Yet, an elevated risk of heart attack and death may be indicated by an unusually high resting heart rate or low maximum heart rate.

Checking one’s resting heart rate is a straightforward action that every one may take. It’s quite simple to execute, and knowing the details now can be useful later. It’s wise to check your pulse from time to time to obtain a sense of what is typical for you. Also, to spot any unusual changes in rate or regularity that may require medical care.

Resting heart rate

Your heart pumps the least quantity of blood when you’re at rest to provide your body the oxygen it needs. Resting heart rates for the majority of healthy adult men and women range from 60 to 100 beats per minute. The Women’s Health Initiative (WHI) published research in 2010 that suggested a resting heart rate at the low end of that range would provide some protection against heart attacks.

Researchers were conducted from the World Heart Institute (WHI) studied data on 129,135 postmenopausal women. They discovered that those with the greatest resting heart rates—more than 76 beats per minute—were 26% more likely to suffer a heart attack or pass away as a result of one than those with the lowest resting heart rates—62 beats per minute or less.

The resting heart rate is regarded as a critical indication by medical professionals because it offers a brief glimpse of how well the heart muscle is working. The resting heart rate can be used to identify potential cardiac issues, according to experts in preventative cardiology. Also, it may show improvements in heart health over time.

You may want to discuss how your heart rate and other personal characteristics affect your risk for cardiovascular disease with your doctor if your resting heart rate is consistently over 80 beats per minute.

Maximum heart rate

Your maximal heart rate is the rate at which your heart beats when it is working the hardest to supply your body with the oxygen it requires. Your aerobic capacity—the amount of oxygen you can take in—is greatly influenced by your maximum heart rate.

According to several sizable observational studies, having a high aerobic capacity reduces your chance of dying from a heart attack and other causes of mortality. Also, small controlled research found that increasing aerobic capacity helped men and women with mild cognitive impairment perform better on memory and reasoning tests.

TACHYCARDIA

Tachycardia is the term for a heart rate of more than 100 beats per minute. It’s important to remember that a rapid heart rate isn’t always unnatural. Your heart rate can be raised by a variety of factors. This includes physical activity, stress, smoking, coffee use, excessive alcohol consumption, and some drugs. A healthcare provider should, however, examine a heart rate that is frequently elevated without any apparent cause. Hyperthyroidism (overactive thyroid), electrolyte imbalances, and high or low blood pressure are all conditions that can cause fast heart rates.

BRADYCARDIA

Bradycardia is a condition in which the heart beats less than 60 times per minute. It can be brought on by drugs, or certain medical diseases, such as hypothyroidism (underactive thyroid), obstructive sleep apnea, and damage or inflammation of the heart muscle. It can also be brought on by chemical imbalances in the blood.

Higher or Lower resting heart rate

According to studies, men in their 50s who have a resting heart rate of 75 beats per minute have a higher risk of developing cardiovascular disease and dying young.

According to the Women’s Health Initiative Research, women are more protected against heart attacks when their resting heart rates are at the lower end of the normal range. Researchers discovered that women with RHRs over 76 heartbeats per minute had a 26% higher risk of having a heart attack than those with RHRs under 62 beats per minute.

Lower heart rates (HR around 60 beats per minute) can signify physical fitness. In other words, if your RHR is under 60, you are probably physically fitter and have better heart health than those whose RHRs are greater. If you don’t engage in regular exercise and have a resting heart rate below 50 beats per minute, it may be a sign of a health issue, such as an issue with the electrical pathways in your heart, such as heart block. You ought to have a qualified medical examination if this is the case.

A high RHR exceeding 100 beats per minute may be caused by stress, excessive coffee use, an infection, a disease, a problem such as heart arrhythmia, or any of several other factors. You should see a doctor if your resting heart rate is continuously above 80 beats per minute and cannot be accounted for by obvious causes, particularly if you are having symptoms like palpitations.

How to lower resting heart rate?

Your gender and genetics, among other uncontrollable variables, can have an impact on your resting heart rate. Your RHR is impacted by several manageable things, though. To reduce your RHR, consider the following health advice:

  • Make sure you work out frequently. Your resting heart rate may decrease by 10–12 beats as a result of this. Your RHR can drop by up to one beat/minute for each week that you engage in physical exercise. Typical RHRs for elite endurance athletes are in the upper 30s or lower 40s.
  • Natural relaxation methods like yoga and meditation might help you feel less stressed and anxious.
  • Reduce your consumption of caffeinated drinks including soda, tea, and coffee.
  • Give up smoking. Nicotine raises your heart rate and is associated with a higher risk of heart disease.
  • Don’t drink excessively. Drinking more than four times daily can strain your heart and make it beat more quickly.
  • With a medical expert, go over your prescriptions. Ask your doctor about any potential effects on your heart rate before beginning a new medicine.

You may experience an increase in RHR if you use certain prescription and over-the-counter medications, including some cold remedies, weight loss medications, and stimulants. Moreover, certain drugs, such as beta-blockers, can cause RHR as a side effect.

Final Comments

The amount of times your heart beats while you’re at rest is known as your resting heart rate (RHR). A lower RHR is typically a sign of greater heart health. A higher chance of getting heart disease and/or having a heart attack is linked to having a high resting heart rate.

The greatest way to lower your resting heart rate is through frequent, strenuous activity. Individuals who regularly engage in physical activity typically have lower resting heart rates than those who lead sedentary lifestyles. If your resting heart rate is unusually low or high, speak with a medical professional.

REFERENCES:

For more details, kindly visit below.

Relation between native language and way of thinking.

Relation between native language and way of thinking.

Comments 0 Comment

Although though some key brain areas are involved in the processing of all languages, these regions exhibit varied activity patterns when processing other languages.

According to the various brain activation patterns seen when processing particular languages, people who speak different native languages would likely have diverse brain structures. According to a recent study, the wiring of the brain regions responsible for language processing differed between native Arabic and German speakers.

These findings imply that learning one’s native language during childhood changes the connections in the brain and may help to explain why people’s ability to think differently depending on their original language.

The native tongue of a person can influence how they think. For instance, Russian has two different terms that distinguish between bright and dark blue, whereas English only has one word for hues in the blue spectrum.

Intriguingly, native Russian speakers typically perform substantially better than native English speakers in examinations requiring the differentiation of light and dark blue. Similar findings have been made about how different native languages express directions and how well-rounded a person’s sense of orientation is.

There are changes in the wiring of language processing regions in the brains of native Arabic and German speakers, according to a recent study published in the journal NeuroImage.

This raises the possibility that acquiring one’s native language as a youngster could alter the brain’s structural makeup, potentially explaining the disparities in cognitive function between people who speak various first languages.

Language processing in the brain

Throughout the years, research has established that a complex network of interconnected brain regions, primarily in the left side or hemisphere of the brain, processes and produces language. Moreover, research has shown that specific brain regions are linked to processing certain components of language, such as semantics (word meaning), syntax (grammatical structure), and phonology (sounds associated with language).

Brain areas in the left hemisphere are principally where syntactic and semantic processing takes place. However, other language-related information, particularly that pertaining to sounds and intonation, is either processed in the right hemisphere or both of them.

In the world, there are close to 7,000 different languages spoken. Individuals with different native languages display varied patterns of brain activation during language processing, despite the fact that the same basic brain regions are engaged in the comprehension and production of all languages.

The brains of people who speak different native languages are structurally different, according to studies. This shows that learning one’s native language throughout childhood causes differences in the brain’s structure from individuals who speak a different first language.

There are two types of brain tissue: grey matter and white matter. The processing of information takes place in the grey matter, which is made up of the cell bodies of neurons or nerve cells. Axons and dendrites, which transmit information from one neuron to the next, make up white matter, on the other hand.

Gray and white matter density in the regions involved in language processing differs between English and Chinese speakers, according to a prior study. In a similar vein, research has revealed variations in the white matter tract patterns connecting several brain regions in native English, German, and Chinese speakers.

Differences in brain connectivity

Researchers compared the differences in the wiring of the brain areas responsible for language processing in speakers of Arabic and German in the current study. These languages were chosen by the researchers because of how differently semantics and syntax are used in each.

First of all, these languages are not related to one another; German is an Indo-German language, while Arabic is a Semitic language. Arabic is more pronounced semantically than German, which has a more complicated grammatical or syntactic framework.

Arabic words frequently lack short vowels, unlike German, and their pronunciation and meaning depend on their context. In addition, German script is written from left to right, whereas Arabic script is written and read from right to left.

Studies have revealed increased syntactic processing activity during German comprehension, which is consistent with this. Others, however, have demonstrated a larger engagement of semantic processing regions during Arabic comprehension. In these investigations, individuals analyse a specific language while magnetic resonance imaging (MRI) is used to look at brain patterns.

Left and right hemispheres connection

The purpose of the current investigation was to determine whether native Arabic and German speakers have structural differences in their brains at baseline as a result of the distinct demands that each language places on the brain.

The researchers specifically looked at whether baseline brain connectivity patterns differed between native German and Arabic speakers. Diffusion-weighted MRI was utilised to find the white matter tracts that link the various parts of the brain.

Both groups’ participants had increased connection in the left hemisphere, which is where language processing is predominately processed. Yet, compared to Arabic speakers, participants whose native language was German had better connections between brain areas involved in language processing in either hemisphere.

Native German speakers, on the other hand, displayed weaker connections between regions in the left and right hemispheres than native Arabic speakers. The right-to-left writing system and the semantic intricacy of Arabic may be to blame for the increased activation of both hemispheres.

Brain scans of German speakers also showed greater connectivity between left hemispheric brain areas involved in syntactic processing. In contrast, native Arabic speakers had stronger connections between the brain regions involved in semantic processing.

Can language change personality?

In conclusion, the current study demonstrates that lifetime exposure to one’s native language causes structural changes in the brain. Dr. Alfred Anwander, a neuropsychologist at the Max Planck Institute and the study’s author, stated:

“The study provides significant evidence for the impact of the environment and first language on brain development, particularly the shaping of the connections that directly affect how our brains process information during thought. This may indicate that unique personality is a product of life experiences rather than being “hard-wired” in our brains.

Dr. Anwander added that the study’s findings might be applied to develop strategies specifically for people with neurological disorders.

Childhood in especially, when the brain still exhibits a larger capacity for adaptation, may leave lasting imprints on our brains and lay the groundwork for the specialised nature of each unique brain. Dr. Alfred Anwander, study author, noted that this may have some implications for clinical situations where individualised treatment may be necessary, such as in neurological rehabilitation strategies, in addition to improving our understanding of how the brain processes various languages differently.

REFERENCES:

For more details, kindly visit below.

Walking steps 1-2 days a week linked to health benefits.

Walking steps 1-2 days a week linked to health benefits.

Comments 0 Comment

According to recent studies, the optimum daily step count for reaping the health advantages of walking is 8,000 brisk steps.

A recent study shows that walking merely one to two days per week is still significantly connected with a decrease in all-cause and cardiovascular mortality, which will inspire people who find it difficult to walk every day of the week.

The authors of the study discovered that the advantages of walking increase with each consecutive day.

Walking briskly for 8,000 steps or more each day of the week is linked to a considerable drop in cardiovascular and all-cause death. Yet, a recent study reveals that those who walk just 8,000 steps on one or two days per week also have a lower mortality rate over a 10-year follow-up.

According to a study published in JAMA Network Open, participants 20 years of age and older who walked 8,000 steps or more on one or two days per week had a 14.9% lower mortality rate than sedentary individuals over the course of ten years of follow-up.

As the number of days engaged rose, the probability of mortality decreased. For instance, exercising three to seven days per week was linked to a 16.5% decrease in cardiovascular and all-cause fatalities.

Those who achieved their step objectives of 6,000 to 10,000 steps per day showed the similar pattern. According to prior studies, the risk of mortality drops by up to 10,000 steps per day for persons under 60 and by 8,000 for those over 60.

Method of exercise

The study’s conclusions apply to both “weekend warriors,” or individuals who limit their exercise to days off from work, and individuals who sneak a few hours of walking throughout the week.

The report cites recent data showing that the average American only takes 4,800 steps per day, which is far too low to have a significant positive impact on health.

The speed limit for “brisk walking” is three miles per hour. You are walking quickly if you can speak song lyrics but not sing them.

The current study analyzed information from the National Health and Nutrition Examination Survey conducted in the United States in 2005 and 2006 with data from the National Death Index until 2019.

It included accelerometer data from 3,101 individuals, who had to be at least 20 years old, and was a sample that was nationally representative. There were almost the same number of males and women in it, and the racial makeup was 50.9% White, 21.5% Black, 23.7% Hispanic, and 3.9% other.

The people who walked 8,000 steps or more per day were more likely to be Hispanic, young, male, insured, and married. Also, they were frequently never smokers and were less likely to be overweight or have concomitant conditions.

A daily challenge of walking

For many people, it takes a significant amount of time to walk 8,000 steps per day. Walking at a speed of three miles per hour, 8,000 steps equals around four miles, or roughly an hour and 20 minutes every day. Steps can be taken in brief bursts of vigorous walking or simultaneously.

Dr. Kosuke Inoue of Kyoto University in Japan served as the study’s principal investigator, working with scientists from UCLA in California. Dr. Inoue provided the following justification for the study:

“We began this study to address a concern raised by one of my patients at an outpatient clinic: ‘It is difficult for me to maintain enough steps each day. Is it acceptable to devote my time to walking exclusively on the weekends?

Dr. Inoue observed a dearth of evidence on the potential advantages of walking merely a few days per week. Steps studies frequently take a week’s worth of various step targets into account.

According to Dr. Inoue, “our findings provide useful information to encourage walking even for a couple of days per week to lower mortality risk,” given that a lack of time is one of the main obstacles to exercise in contemporary society.

According to Dr. Paul Arciero, a professor in the Skidmore College Department of Health and Human Physiological Sciences who was not involved in the study, “This is one of the first studies to employ direct assessments of daily steps using a wearable accelerometer throughout a 10-year follow-up period.”

Walking benefits overall health

Walking is regarded as a straightforward, low-impact way to reduce someone’s inactive lifestyle. Sedentary behaviour has been associated with a higher risk of cardiovascular and all-cause mortality.

Dr. Arciero continued, “Furthermore, a sedentary lifestyle dramatically raises the risk of cardiometabolic disease, including abdominal obesity, hypertension (high blood pressure), type 2 diabetes, stroke, heart disease, and some inflammatory disorders and malignancies.”

Walking can help someone keep a healthy weight, build stronger muscles and bones, and reduce their chance of developing diabetes, heart disease, and high blood pressure. Another thing that has been connected to improving mood is walking.

The Harvard Medical School claims that walking has additional, less evident advantages. Walking counteracts the effects of genes that make you gain weight, lowers your risk of developing breast cancer, and strengthens your immune system. Walking can help alleviate joint pain caused by arthritis, and even a brief stroll of 15 minutes can stop a general or stress-related chocolate appetite.

limited time for walking

According to Dr. Inoue, the study’s findings should be useful information for clinicians and other health professionals. He advised that the key message for readers should be that, for those who find it difficult to exercise regularly, “reaching required daily steps merely a few days per week can have considerable health advantages.”

Dr. Arciero referred to the study’s findings as “encouraging,” and he proposed that they might assist those who don’t have enough time to walk 8,000 steps a day in overcoming the belief that walking less is ineffective.

Dr. Arciero declared, “We now have scientific proof that shows this thinking is false, and even a couple of days is helpful. The study, according to him, emphasizes the importance of boosting one’s daily step count.

It’s a wonderful reminder to walk at least once or twice a week because even a little bit is better than nothing.

Current guidelines

The American Heart Association (AHA) and Department of Health and Human Services (HHS) advise aiming for at least 150 minutes of moderate-intensity aerobic activity per week, along with two days of muscle-strengthening activity.

The AHA urges people to move about more and notes that even modest exercise can counteract some of the negative impacts of sedentary lifestyles. Yet, the AHA also asserts that spending at least 300 minutes a week engaged in physical activity can provide even greater advantages.

Yet, Dr. Heffron notes that even the most fundamental aims are rarely achieved by the majority of people. According to statistics from the Centers for Disease Control and Prevention, just 47% of Americans fulfil the aerobic criteria and 24% do both aerobic and strength training recommendations (CDC).

REFERENCES:

For more details, kindly visit below.

New drug combination reduces Lung cancer tumors.

New drug combination reduces Lung cancer tumors.

Comments 0 Comment

The second most frequent type of cancer in the world is lung cancer. Around 2 million people are given a lung cancer diagnosis each year, and 1.8 million people pass away from the condition.

Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) are the two forms of lung cancer, with NSCLC accounting for the majority of instances. Surgery, radiation, and chemotherapy are all effective treatments for NSCLC, although it is rarely curable.

Today, studies have discovered that a combination of two medications reduces the size and quantity of tumours in mice with NSCLC, a finding that could result in human clinical trials.

Lung cancer is the second most prevalent cancer diagnosed in the United States, according to the American Cancer Society. Moreover, it is the main cause of cancer mortality, accounting for one in five cancer-related deaths, more than colon, breast, and prostate cancers put together.

The typical age of diagnosis for lung cancer is 70 years old, with most cases being found in older patients. The good news is that cases are declining as fewer individuals smoke tobacco, which is responsible for more than 80% of lung cancer cases. A diagnosis of lung cancer is still given to over 2 million people annually worldwide.

Lung tumours other than small cell comprise 85% of cases (NSCLCs). There is an urgent need for novel therapies because immunotherapy and chemotherapy are not very successful against this kind of lung cancer.

Now, researchers from the Salk Institute and Northwestern University have discovered that treating NSCLC-affected mice with a cocktail of two drugs—one of which is already approved by the Food and Drug Administration (FDA) and the other is undergoing clinical trials—reduced the size and frequency of the tumours.

Need for new treatments

According to Dr. Lillian Eichner, a principal author of the study and an assistant professor of biochemistry and molecular genetics at Northwestern University, “This medication might be helpful for patients with KRAS/LKB1 mutant lung adenocarcinoma.”

About 20,000 new cases of this disease’s molecular subtype are reported each year in the United States, she said. “Patients with this terrible disease currently have an average survival duration of 10 months after diagnosis, and improved therapeutic techniques are desperately needed.”

Histone deacetylase (HDAC) inhibitors have been suggested as a possible therapy for this particular form of lung cancer by the researchers. Animal tumour growth has been demonstrated to be slowed by HDAC inhibitors, which are epigenetic regulators.

After proving that HDAC3 was essential for the development of difficult-to-treat LKB1-mutant cancers, the study’s authors investigated if pharmacologically inhibiting HDAC3 may have an impact on tumour growth.

In this study, they treated KRAS/LKB1 mutant NSCLC in mice with two different medications: the FDA-approved MEK inhibitor trametinib and the HDAC1/HDAC3 inhibitor entinostat, which is currently in clinical development.

Lung tumor study

The LKB1 genetic mutation is present in NSCLCs, and Salk researchers were interested in investigating a novel targeted therapeutic option.

According to Dr. Andrew McKenzie, vice president of personalised medicine at Tennessee’s Sarah Cannon Research Institute and scientific director at Genospace, targeted therapies are medicines created for certain molecular subtypes of NSCLCs.

Since that these treatments are “tailored,” he explained, “it is preferable to administer a targeted therapy rather than immunotherapy or immunotherapy and chemotherapy if you test a patient and discover a mutation.

Initially, the Salk team demonstrated that the body’s histone deacetylase 3 (HDAC3) protein is essential for the development of NSCLCs with the LKB1 mutation.

This was unexpected, according to co-lead of the study Lillian Eichner, PhD, a professor at Northwestern University in Illinois who was a postdoctoral researcher at Salk during the research.

She said, “We believed the entire HDAC enzyme class was intimately related to the origin of LKB1 mutant lung cancer.

“We didn’t know the exact involvement of HDAC3 in lung tumour formation,” Eichner stated. She then moved to two drugs with the assistance of the team.

The potent drug combination

Entinostat was the first medication. Although the Food and Drug Administration (FDA) has not yet approved this medication, clinical tests have demonstrated that it targets HDACs.

Trametinib was the second medication and it works by preventing the growth of cancer cells. Trametinib is FDA-approved for the treatment of NSCLCs, but it must be used in conjunction with the medication dabrafenib, McKenzie added.

These two medications are only permitted for use in NSCLCs with the BRAF V600E mutation, the author continued.

According to McKenzie, “Trametinib on its own has not been very effective and requires to be paired with dabrafenib to see the clinical outcomes associated with FDA approval.” Because trametinib might cause tumours to become resistant, dabrafenib is often used in conjunction with it.

The goal of the study was to determine whether trametinib and the HDAC3-targeting drug entinostat would reduce resistance in the same way. Mice with LKB1-mutated NSCLC were treated with the medication cocktail for 42 days, and then the tumours were examined again.

Tumors in recipient mice have shrunk by 79% in size compared to mice not receiving the medication treatment. The researchers also noted a 63% decrease in lung cancers in the treated animals.

Human trials needed

Cancers are already being treated with these medications. For the first time, the FDA approved trametinib in 2013 to treat metastatic malignant melanoma. In 2017, it received approval for the treatment of NSCLC.

Entinostat has undergone phase 1 and phase 2 clinical trials but has not yet received FDA approval for clinical usage. Phase 3 trials in people with breast cancer are also still being conducted. People have typically tolerated the medication well during the studies.

The medications have not yet been combined in human subjects. The following stages in evaluating the combined therapy were described by Dr. Eichner.

She said that in order to determine the safety of this combined therapeutic method, a phase 1 clinical research would be conducted first.

“Based on the known safety profiles of both medications, we are hoping that this would also be the case in people,” said Dr. Eichner. “Our preclinical investigations were extremely encouraging with regard to the safety of this pharmacological combination.”

A phase 2 research would then determine whether this combination inhibits tumour growth and lengthens the patients’ lives, she continued.

New hope for cancer patients

On average $1.3 billion is spent to bring a new treatment to market, according to a recent study, making drug development a time-consuming and expensive process.

Also, it often takes 6 to 12 years for new cancer medications to be approved. So, it is quicker and more cost-effective to identify new ways to use existing medications.

According to our research, cancer treatments that were previously unsuccessful might be successful if they are modified. In some cases, understanding basic tumour biology can result in novel cancer therapy strategies without the need to first create new medications, which can be a lengthy process, according to Dr. Lillian Eichner.

Although it is still early, their discoveries might result in new lung cancer medicines for this difficult-to-treat disease. Dr. Eichner is upbeat, but more study is required to validate the results.

According to “our findings,” treating patients concurrently with both of these already-approved medications “may significantly limit the growth of lung tumours for this set of patients.”

REFREENCES:

For more details, kindly visit below.